Sanofi SA (ADR) (NYSE:SNY) Walks Out From KaloBios Pharmaceuticals Inc (NASDAQ:KBIO)’s KB001-A Deal

Boston, MA 07/29/2014 (wallstreetpr) – During the 2013’s era of biotech boom, KaloBios Pharmaceuticals Inc (NASDAQ:KBIO) had debuted on the exchange with high promises to deliver, which had instantly caught attention of giants like Sanofi SA (ADR) (NYSE:SNY). The latter had agreed to partner KaloBios in a deal by paying $35 million and had announced […]